Results 241 to 250 of about 171,978 (359)

Expression of Foxp3 in non-small cell lung cancer patients is significantly higher in tumor tissues than in normal tissues, especially in tumors smaller than 30 mm

, 2006
Yasunori Ishibashi, Shigebumi Tanaka, Kohei Tajima, Takeshi Yoshida, Hiroyuki Kuwano   +4 more
openalex   +2 more sources

Role of IFN-g in induction of Foxp3 and conversion of CD4+CD25- T cells to CD4+ Tregs [PDF]

, 2006
Zhaojun Wang
openalex   +1 more source

Effects of immune checkpoint inhibitors on the pulmonary circulation in lung cancer patients

International Journal of Cancer, EarlyView.
What's New? Immune checkpoint inhibitors (ICIs) are effective against various cancers, but as more patients receive these therapies, more immune‐related adverse events (irAEs) emerge. Recent studies have suggested that ICIs are associated with an increase in pulmonary artery diameter and the ratio between pulmonary artery diameter and aortic diameter ...
Yao Xu, Qiuhong Zhang, Jie Gao, Shiyuan Yao, Chan Tian, Tuo He, Ming Zhang, Hu Shan, Jie Shi, Bo Yuan, Lei Wang, Xia Yang   +11 more
wiley   +1 more source

Comparative profiling of T cell and macrophage subsets in cutaneous squamous cell carcinoma and basal cell carcinoma. [PDF]

Sci Rep
Winter L, Ries J, Vogl C, Trumet L, Geppert CI, Scholtysek C, Olmos M, Kesting M, Weber M.   +8 more
europepmc   +1 more source

Glucocorticoid amplifies IL‐2‐dependent expansion of functional FoxP3⁺CD4⁺CD25⁺ T regulatory cells in vivo and enhances their capacity to suppress EAE [PDF]

, 2006
Xin Chen, Joost J. Oppenheim, Robin Winkler-Pickett, John R. Ortaldo, O. M. Zack Howard   +4 more
openalex   +1 more source

Integrated scFv identification and CAR T cell generation for AML targeting in vivo

International Journal of Cancer, EarlyView.
What's New? Acute myeloid leukemia (AML) is a rapidly progressing blood cancer. Advancing chimeric antigen receptor (CAR) T cell therapies, particularly through rapid translation of single chain variable fragment (scFv) discovery into CAR constructs, may improve clinical outcomes, especially the development of patient individualized CAR T cells.
Yi Liu, Annika Lauk, David Sedloev, Josephine Brysting, Ela Cetin, Chunan Liu, Maximilian Mönnig, Thomas Luft, Haiyang Yun, Michael Schmitt, Tim Sauer, Fengbiao Zhou, Christian Rohde, Carsten Müller‐Tidow   +13 more
wiley   +1 more source

Regulatory T cells in homeostasis and disease: molecular mechanisms and therapeutic potential. [PDF]

Signal Transduct Target Ther
Wang L, Liang Y, Zhao C, Ma P, Zeng S, Ju D, Zhao M, Yu M, Shi Y.   +8 more
europepmc   +1 more source

Characterization of Foxp3+CD4+CD25+ and IL-10-Secreting CD4+CD25+ T Cells during Cure of Colitis

, 2006
Holm H. Uhlig, Janine L. Coombes, Christian Mottet, Ana Ízcue, Claire Hartmann‐Thompson, Andrea Fanger, Andrea Tannapfel, Jason D. Fontenot, Fred Ramsdell, Fiona Powrie   +9 more
openalex   +1 more source

New trend in molecular diagnostics: Insights from the tumor microenvironment

Interdisciplinary Medicine, EarlyView.
The graphical abstract outline the key elements in TME‐based molecular diagnostics, including biomarker exploration, diagnostic methods, and diagnostic models. Source: Created with BioRender.com. Abstract Molecular diagnosis has revolutionized cancer precision medicine.
Baiyuan Fan, Jiahui Zhang, Chong Li, Xu Zhang   +3 more
wiley   +1 more source

From rough to refined: Applying diamond standards to CAR Treg development. [PDF]

Mol Ther Methods Clin Dev
Hamilton FW, Ferreira LMR.
europepmc   +1 more source